Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritis.
Saved in:
| Title: | Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritis. |
|---|---|
| Authors: | Gangaiah D; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Ryan V; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Van Hoesel D; Division of Nanobody Discovery and Development, QVQ Holding BV, Utrecht, The Netherlands., Mane SP; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Mckinley ET; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Lakshmanan N; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Reddy ND; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA., Dolk E; Division of Nanobody Discovery and Development, QVQ Holding BV, Utrecht, The Netherlands., Kumar A; Division of Bacteriology and Microbiome, Elanco Animal Health, Greenfield, Indiana, USA. |
| Source: | MicrobiologyOpen [Microbiologyopen] 2022 Apr; Vol. 11 (2), pp. e1270. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101588314 Publication Model: Print Cited Medium: Internet ISSN: 2045-8827 (Electronic) Linking ISSN: 20458827 NLM ISO Abbreviation: Microbiologyopen Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-8827 |
|---|---|
| DOI: | 10.1002/mbo3.1270 |
